InnovAge Holding Corp (INNV) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
InnovAge Holding Corp stock (INNV) is currently trading at $8.13. InnovAge Holding Corp PE ratio is 159.20. InnovAge Holding Corp PS ratio (Price-to-Sales) is 1.18. Analyst consensus price target for INNV is $7.00. WallStSmart rates INNV as Sell.
- INNV PE ratio analysis and historical PE chart
- INNV PS ratio (Price-to-Sales) history and trend
- INNV intrinsic value — DCF, Graham Number, EPV models
- INNV stock price prediction 2025 2026 2027 2028 2029 2030
- INNV fair value vs current price
- INNV insider transactions and insider buying
- Is INNV undervalued or overvalued?
- InnovAge Holding Corp financial analysis — revenue, earnings, cash flow
- INNV Piotroski F-Score and Altman Z-Score
- INNV analyst price target and Smart Rating
InnovAge Holding Corp
📊 No data available
Try selecting a different time range
INNV Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · InnovAge Holding Corp (INNV)
INNV trades 2306% above its Graham fair value of $0.34, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
InnovAge Holding Corp (INNV) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
InnovAge Holding Corp (INNV) Key Strengths (1)
Paying $1.18 for every $1 of annual revenue
Supporting Valuation Data
InnovAge Holding Corp (INNV) Areas to Watch (8)
Earnings declining -87.80%, profits shrinking
Very low returns on shareholder equity
Very thin margins with limited operational efficiency
Very thin margins, barely profitable
Very low institutional interest at 12.70%
Premium pricing at 4.1x book value
Small-cap company with higher risk but more growth potential
Solid revenue growth at 14.70% per year
Supporting Valuation Data
InnovAge Holding Corp (INNV) Detailed Analysis Report
Overall Assessment
This company scores 31/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 1 register as strengths (avg 8.0/10) while 8 fall into concern territory (avg 2.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales. Valuation metrics including Price/Sales (1.18) suggest the stock is attractively priced.
The Bear Case
The primary concerns are EPS Growth, Return on Equity, Operating Margin. Some valuation metrics including Price/Book (4.10) suggest expensive pricing. Growth concerns include Revenue Growth at 14.70%, EPS Growth at -87.80%, which may limit upside. Profitability pressure is visible in Return on Equity at 1.18%, Operating Margin at 5.53%, Profit Margin at 0.71%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 1.18% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 14.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. EPS Growth and Return on Equity are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
INNV Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
INNV's Price-to-Sales ratio of 1.18x trades 16% below its historical average of 1.4x (57th percentile). The current valuation is 81% below its historical high of 6.09x set in Apr 2021, and 123% above its historical low of 0.53x in Mar 2025. Over the past 12 months, the PS ratio has expanded from ~0.5x, reflecting growing market expectations outpacing revenue growth.
Compare INNV with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for InnovAge Holding Corp (INNV) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
InnovAge Holding Corp operates as a stable business with moderate growth and solid fundamentals. Revenue reached 915M with 15% growth year-over-year. Profit margins are thin at 0.7%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 19M in free cash flow and 21M in operating cash flow. Earnings are translating into actual cash generation.
ROE of 1.2% suggests the company isn't efficiently converting equity into profits.
Earnings fell 88% YoY while revenue grew 15%. This gap usually reflects one-time items (tax benefits, write-offs) in the prior period, not an operational decline.
What to Watch Next
Margin expansion: can InnovAge Holding Corp push profit margins above 15% as the business scales?
Valuation compression risk at a P/E of 159.2x. Any growth miss could trigger a sharp correction.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact InnovAge Holding Corp.
Bottom Line
InnovAge Holding Corp offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About InnovAge Holding Corp(INNV)
NASDAQ
HEALTHCARE
MEDICAL CARE FACILITIES
USA
InnovAge Holding Corp. The company is headquartered in Denver, Colorado.